Pacer Advisors’s 89bio ETNB Stock Holding History

Pacer Advisors’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-816	Closed	-$6.54K	–	2605
2024 Q2	$6.54K	Sell	816 -1,330	-62%	-$11.9K	﹤0.01%	3608
2024 Q1	$25K	Buy	+2,146	New	+$23.8K	﹤0.01%	3398

Other funds holding ETNB

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Pacer Advisors's ETNB Position: Q3 2024 in Review

Pacer Advisors sold out of 89bio (ETNB) in Q3 2024, closing a stake of 816 shares — an estimated $6.54K sold.

Pacer Advisors first reported a position in ETNB in Q1 2024 and held it in 2 quarters. The position peaked at $25K in Q1 2024. 144 funds tracked by Wall St. Rank hold ETNB as of Q3 2024.

Pacer Advisors reported no remaining 89bio position as of Q3 2024 after selling out during the quarter.
Pacer Advisors sold 816 89bio shares in Q3 2024, an estimated $6.54K.
Pacer Advisors first reported a position in 89bio in Q1 2024 and held it in 2 quarters.
Pacer Advisors's 89bio position peaked at $25K in Q1 2024.
144 funds tracked by Wall St. Rank held 89bio as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.